RT Journal
A1 Goldberger ZD, Fagerlin A
T1 Icds—increasingly complex decisions: Comment on “patient preference in the decision to place implantable cardioverter-defibrillators”
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2012
FD July 23
VO 172
IS 14
SP 1106
OP 1107
DO 10.1001/archinternmed.2012.2660
UL http://dx.doi.org/10.1001/archinternmed.2012.2660
AB 
The clear benefits of implantable cardioverter-defibrillators (ICDs) in selected populations have been consistently demonstrated through landmark investigations for more than 2 decades.1 After initially demonstrating efficacy in secondary prophylaxis of sudden cardiac death (SCD),2 ICDs are now first-line therapy for primary prophylaxis of SCD in many patients with ischemic or nonischemic cardiomyopathy.3- 4